Lupin Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lupin Ltd with three other
companies in this sector in INDIA :
sales of 163.62 billion Indian Rupees [US$2.17 billion]
of which 99%
Aurobindo Pharma Ltd
(195.64 billion Indian Rupees [US$2.60 billion]
of which 100%
was Pharmaceuticals), and
Dr.Reddy's Laboratories Ltd
(153.85 billion Indian Rupees [US$2.04 billion]
of which 80%
was Global Generics).
Lupin Ltd reported sales of 167.18 billion Indian Rupees (US$2.22 billion)
March of 2019.
increase of 5.8%
versus 2018, when the company's sales were 158.04 billion Indian Rupees .
Despite this increase, sales are still
below the level achieved in 2017, when Lupin Ltd
reported sales of 174.94 billion Indian Rupees .